ArticleJournal of cellular immunology2022

Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer's Disease than Amyloid or Tau.

Tyler C Hammond et al.PubMed ↗Full text ↗

No numbers read from the abstract.